OncoDaily 2025 reflected a year of rapid progress in oncology, shaped by new scientific discoveries, clinical innovations, and stronger global collaboration. Throughout this dynamic year, OncoDaily focused on one clear goal: providing timely, accurate, and clinically relevant oncology information to clinicians, researchers, and healthcare professionals worldwide. In addition to scientific reporting, OncoDaily conducted on-site interviews with leading oncologists, capturing expert perspectives and firsthand insights into their research, clinical experience, and emerging trends in cancer care.
Over the course of the year, OncoDaily provided comprehensive coverage of the most influential oncology congresses and educational forums worldwide. From large multidisciplinary meetings to highly specialized scientific summits, our reporting focused on translating complex data into meaningful insights that support evidence-based cancer care.
Flagship International Congresses: ASCO and ESMO
Major international congresses formed the backbone of this effort. Coverage of ASCO 2025 and ESMO 2025 focused on pivotal late-breaking trials, practice-changing therapeutic advances, and evolving standards of care across solid tumors and hematologic malignancies. Particular attention was given to data with immediate clinical relevance, including survival outcomes, biomarker-driven treatment strategies, and safety profiles that inform real-world decision-making.
Read the full article here.
These meetings set the tone for the year by highlighting continued progress in immunotherapy, targeted agents, antibody–drug conjugates, and precision oncology, while also addressing ongoing challenges such as treatment resistance, toxicity management, and access to innovative therapies. By combining trial data with expert interpretation and on-site insights, OncoDaily aimed to provide a clear and balanced view of both advances achieved and unmet needs guiding future research.
Read the full article here.Â
Disease-Specific and Population-Focused Insights
Disease-specific and population-focused meetings further enriched OncoDaily’s scientific reporting. The San Antonio Breast Cancer Symposium and ESMO GI 2025 offered in-depth perspectives on breast and gastrointestinal cancers, with detailed coverage of translational research, biomarker-driven strategies, and long-term outcome data.
Read the full article here.Â
The CTOS Annual Meeting provided essential insights into sarcoma research, rare tumor management, and innovative trial designs, ensuring visibility for areas often underrepresented in broader oncology discourse.
Read the full article here
SIOG 2025 placed a strong spotlight on geriatric oncology, highlighting the growing need for age-adapted treatment strategies that account for comorbidities, functional status, frailty, and patient preferences. The meeting reinforced the importance of individualized, patient-centered decision-making in older adults with cancer, with a focus on balancing treatment efficacy, toxicity, quality of life, and long-term outcomes in an aging global population.
Read the full article here.Â
Radiation Oncology
Radiation oncology remained a key pillar of coverage in 2025. Reporting from ASTRO 2025 and ESTRO 2025 focused on technological advances, adaptive and image-guided radiotherapy, stereotactic approaches, and the integration of radiotherapy with systemic treatments. These meetings underscored the increasingly central role of precision radiotherapy in multidisciplinary cancer care.
Expanding Perspectives: Multidisciplinary Fields
Beyond traditional tumor-focused congresses, OncoDaily expanded its coverage of cross-disciplinary and emerging fields. The Global Cardio-Oncology Summit addressed the growing intersection between cancer therapy and cardiovascular health, reflecting the field’s shift toward survivorship and long-term toxicity management.
Read the full article here.Â
The European Cancer Summit and ECHoS emphasized cancer policy, prevention, health systems, and equity, highlighting the importance of translating scientific progress into population-level impact. SIO Integrative Oncology showcased complementary approaches that support symptom control, quality of life, and holistic patient care.
Read the full article here.Â
Education, Training, and Global Collaboration
Educational and regional initiatives also played an important role throughout the year. Coverage of the 7th CUHK Masterclass and the MASSC 2025 Meeting emphasized global knowledge exchange, training, and collaboration across healthcare systems and regions. These meetings reinforced the value of education-driven platforms in strengthening oncology practice worldwide.
Read the full article here.Â
Read the full article here.Â
Looking Ahead to 2026
Across all these events, OncoDaily’s coverage aimed to go beyond headline reporting. Scientific sessions were contextualized within existing evidence, key data points were highlighted with clinical relevance in mind, and emerging trends were followed longitudinally across meetings. This approach ensured continuity, depth, and reliability—qualities essential for navigating an increasingly complex oncology landscape.
As 2025 comes to a close, it is clear that this year marked another step forward in cancer research and care. From novel therapeutics and biomarker-guided strategies to multidisciplinary integration and survivorship-focused care, the oncology community demonstrated resilience, innovation, and shared commitment to improving patient outcomes.
Stay connected with OncoDaily for the latest developments in global oncology.